Dianthus Therapeutics
DNTH
DNTH
93 hedge funds and large institutions have $276M invested in Dianthus Therapeutics in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
25% less capital invested
Capital invested by funds: $366M → $276M (-$90.3M)
Holders
93
Holding in Top 10
2
Calls
$86K
Puts
–
Top Buyers
| 1 | +$4.04M | |
| 2 | +$3.99M | |
| 3 | +$3.75M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$3.5M |
| 5 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$3.41M |
Top Sellers
| 1 | -$9.1M | |
| 2 | -$3.59M | |
| 3 | -$2.42M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.35M |
| 5 |
O
OrbiMed
New York
|
-$1.03M |